UB Paderborn / Katalog / Suche / in CDI

Bivalirudin for Patients with Acute Coronary Syndromes

The New England journal of medicine, 2006-11, Vol.355 (21), p.2203-2216

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention

Journal of the American College of Cardiology, 1999-01, Vol.33 (1), p.88-96

1999

Link zum Volltext

Verfügbarkeit prüfen

Intravenous Platelet Blockade with Cangrelor during PCI

The New England journal of medicine, 2009-12, Vol.361 (24), p.2330-2341

2009

Link zum Volltext

Verfügbarkeit prüfen

Results of prevention of REStenosis with tranilast and its outcomes (PRESTO) trial

Circulation (New York, N.Y.), 2002-09, Vol.106 (10), p.1243-1250

2002

Link zum Volltext

Verfügbarkeit prüfen

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial

JAMA : the journal of the American Medical Association, 2014-01, Vol.311 (3), p.252

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox)

The American journal of cardiology, 2002-07, Vol.90 (1), p.42-45

2002

Link zum Volltext

Verfügbarkeit prüfen

Outcomes Following Pre-Operative Clopidogrel Administration in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery: The ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

Journal of the American College of Cardiology, 2009-05, Vol.53 (21), p.1965-1972

2009

Link zum Volltext

Verfügbarkeit prüfen

Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial

JAMA : the journal of the American Medical Association, 2007-12, Vol.298 (21), p.2497

2007

Link zum Volltext

Verfügbarkeit prüfen

Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial

JAMA : the journal of the American Medical Association, 2007-02, Vol.297 (6), p.591

2007

Link zum Volltext

Verfügbarkeit prüfen

Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization

The American journal of medicine, 2002-07, Vol.113 (1), p.1-6

2002

Link zum Volltext

Verfügbarkeit prüfen

The influence of peripheral arterial disease on outcomes : A pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials

Journal of the American College of Cardiology, 2006-10, Vol.48 (8), p.1567-1572

2006

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of Switching From Either Unfractionated Heparin or Enoxaparin to Bivalirudin in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Managed With an Invasive Strategy : Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

Journal of the American College of Cardiology, 2008-05, Vol.51 (18), p.1734-1741

2008

Link zum Volltext

Verfügbarkeit prüfen

Anthracycline-induced cardiotoxicity

Annals of internal medicine, 1996-07, Vol.125 (1), p.47

1996

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention : 1-Year Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

Journal of the American College of Cardiology, 2008-09, Vol.52 (10), p.807-814

2008

Link zum Volltext

Verfügbarkeit prüfen

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

The New England journal of medicine, 1999-07, Vol.341 (5), p.319-327

1999

Link zum Volltext

Verfügbarkeit prüfen

The role of spironolactone in the treatment of patients with refractory hypertension

American journal of hypertension, 2002-04, Vol.15 (4), p.333-339

2002

Link zum Volltext

Verfügbarkeit prüfen

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention : Results of the gold (AU-assessing ultegra) multicenter study

Circulation (New York, N.Y.), 2001-05, Vol.103 (21), p.2572-2578

2001

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease

Circulation (New York, N.Y.), 1998-12, Vol.98 (25), p.2829-2835

1998

Link zum Volltext

Verfügbarkeit prüfen

Meta-Analysis Comparing Reported Frequency of Atrial Fibrillation After Acute Coronary Syndromes in Asians Versus Whites

The American journal of cardiology, 2008-02, Vol.101 (4), p.506-509

2008

Link zum Volltext

Verfügbarkeit prüfen

Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT)

The American journal of cardiology, 2002-11, Vol.90 (9), p.916-921

2002

Link zum Volltext

Verfügbarkeit prüfen

Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions

The American journal of cardiology, 2004-07, Vol.94 (1), p.30-34

2004

Link zum Volltext

Verfügbarkeit prüfen

Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial

JAMA : the journal of the American Medical Association, 2002-11, Vol.288 (17), p.2130

2002

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Bivalirudin for Patients with Acute Coronary Syndromes

2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non―ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): A Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines

Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention

Intravenous Platelet Blockade with Cangrelor during PCI

Results of prevention of REStenosis with tranilast and its outcomes (PRESTO) trial

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial

Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox)

Outcomes Following Pre-Operative Clopidogrel Administration in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery: The ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial

Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial

2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization

The influence of peripheral arterial disease on outcomes : A pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials

Safety and Efficacy of Switching From Either Unfractionated Heparin or Enoxaparin to Bivalirudin in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Managed With an Invasive Strategy : Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

Anthracycline-induced cardiotoxicity

Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention : 1-Year Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

The role of spironolactone in the treatment of patients with refractory hypertension

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention : Results of the gold (AU-assessing ultegra) multicenter study

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease

Meta-Analysis Comparing Reported Frequency of Atrial Fibrillation After Acute Coronary Syndromes in Asians Versus Whites

Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT)

Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions

Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial

Aktive Filter

Suchergebnisse filtern